Siamab Therapeutics' Series C Round

Siamab Therapeutics raised a round of funding on April 09, 2015. Investors include Boston Harbor Angels.

Siamab Therapeutics, formerly Sialix, is a biopharmaceutical company developing cancer immunotherapies. Siamab has developed a platform of technologies that enable the discovery and development of the…

Articles about Siamab Therapeutics' Series C Round: